Research study Program year 2021 Source: CMS Open Payments

Dea Laa

Research payments

$454,483

14 payments

Through program year 2021, $454,483 in research payments was reported against Dea Laa, across 14 payments, paid by Boehringer Ingelheim Pharmaceuticals, Inc..

Paid by: Boehringer Ingelheim Pharmaceuticals, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$72,733	5
2020	Research	$140,153	4
2019	Research	$241,597	5

Breakdown

Who paid Research payments · program years 2019–2021

Boehringer Ingelheim Pharmaceuticals, Inc. $454,483 14 payments

Who received the money Research payments · program years 2019–2021

Vanderbilt University Medical Center Organisation paid for research $133,874 1 payment
Heart Center Research LLC Organisation paid for research $59,477 2 payments
Grandview Med Group Research Organisation paid for research $59,031 2 payments
The University Of Kansas Hospital Pharmacy Organisation paid for research $58,559 3 payments
Vanderbilt University Medical Center Teaching hospital · TN $51,636 2 payments
Investigational Drug Service Organisation paid for research $39,558 2 payments
Alabama Cardiovascular Group Organisation paid for research $32,447 1 payment
Affinity Crdvsclr Specialists Organisation paid for research $19,901 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

1 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

Christopher Ellis Nashville, TN Named on 14 payments

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.